We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Trellus Health plc (TRLS) ORD GBP0.0006

Sell:0.55p Buy:0.60p 0 Change: No change
Market closed |  Prices as at close on 27 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:0.55p
Buy:0.60p
Change: No change
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 27 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:0.55p
Buy:0.60p
Change: No change
Market closed |  Prices as at close on 27 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Trellus Health plc is a United Kingdom-based health services company, which is engaged in providing solutions and services for chronic condition management. The Company is focused on chronic costly GI conditions that have high mental health burden, such as inflammatory bowel disease (IBD) which includes the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The Company has one division being the providing resilience-driven care for chronic conditions in the inflammatory bowel disease state. The Company’s Trellus Elevate platform is a connected health platform that incorporates the Gaining Resilience Through Transitions (GRITT) methodology and learnings on resilience from clinical research and practice. Trellus Elevate’s personalized health roadmaps include engaging lessons and skill-building techniques designed to empower individuals. The Company’s wholly owned subsidiary is Trellus Health Inc.

Contact details

Address:
Avon House, 19 Stanwell Road
PENARTH
CF64 2EZ
United Kingdom
Telephone:
+ (0)
Website:
https://trellushealth.com/

Important dates

Future events
There are no future events available.
Past events
Interim results 26 September 2024 26/09/24
AGM 14 June 2024 14/06/24
Annual report 20 May 2024 20/05/24
Final results 23 April 2024 23/04/24

General stock information

EPIC:
TRLS
ISIN:
GB00BNNFM402
Market cap:
£928,673
Shares in issue:
161.51 million
Sector:
No specific Industry
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Marla Dubinsky
    Chief Executive Officer, Executive Director
  • Joy Bessenger
    Chief Financial Officer
  • Salim Hamir
    Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.